INTRODUCTION
Hepatitis C virus (HCV) infection represents a major public health problem in Brazil and in the world. Most of the cases are asymptomatic HCV carriers, but chronic infection occurs in approximately 85% of the infected individuals that can progress into liver cirrhosis and hepatocarcinoma. The HCV was identified in 1989 by researchers from Chiron Corporation and it is responsible for about 90% of the so-called non-A non-B hepatitis. 1 Presently, cirrhosis caused by chronic hepatitis C is the leading indication for liver transplantation in United States of America 2,3 and in Brazil. 4 After tests to detect anti-HCV became available, a number of studies have been conducted to estimate the prevalence of HCV infection in the general population. [5] [6] [7] [8] [9] The World Health Organization (WHO) data suggests a worldwide prevalence of 2.2%-3.0%, with the highest prevalence found in the African and the Eastern Mediterranean regions. 10 Brazilian studies on this subject have been predominantly targeted risk groups [11] [12] [13] [14] and blood donors. 15, 16 Only few investigators have addressed the prevalence of hepatitis C in the general population or in minority groups. 17 Focaccia et al., for example, found 1.42% of anti-HCV positive results in the population of São Paulo. 18 In Brazilian blood donors, the anti-HCV prevalence was found to be 1.6%. 13 In the South Region the prevalence in general population and blood donors was estimated in 0.15% 14, 19 and 0.46%, 20 respectively. Considering data from public health department, the Paraná State from 2003 to 2006 has an accumulated detection of 21.11 cases of hepatitis C per 100,000 inhabitants. But in Tamboara, this rate was estimated on 581.95. 21 Based on this fact, we conducted a study to investigate the prevalence of anti-HCV in Tamboara residents and to elucidate the risk factors associated with HCV transmission in this population. The results should help sanitary authorities to set up policy decisions for Tamboara. For this community-based seroepidemiological survey, HCV Rapid Test was used and validated by AR-CHITECT quimioluminescent immunoassay.
MATERIALS AND METHODS

Study population
This study was performed in Tamboara, a small town with 4,564 inhabitants of the Paraná State, south Brazil. The town was divided in different areas which were visited by groups of two investigators. Each house of urban area has been systematically visited by a trained nursing student. One resident for each house, independently of age, was selected by at random and invited to participate in the study. Blood sample and a questionnaire on the risk factors for hepatitis C were obtained from each subject after the informed consent was signed. In the case of minors, the informed consent was signed by their parents. The questionnaire consist of questions regarding demographic variables, familial history of hepatitis, various potential parenteral exposure to blood or blood products before and after 1993, history of parenteral injections and intravenous drips, sexual behavior, as well as dental treatment, previous surgery, tattooing, etc. The study protocol was approved conformed to the ethical guidelines of the 1975 Declaration of Helsinki, as reflected in a priori approval by the institution's Human Research Committee.
Laboratory testing
The HCV Rapid Test Bioeasy (Bioeasy Diagnostica Ltda, Minas Gerais, Brazil), an immuno-chromatographic assay for HCV antibodies qualitative detection was used according to the manufacturer's instructions. Briefly, total blood from each subject was obtained by lancing device against the chosen puncture finger and 10µL was aspirated with a micropipette. The blood was deposited in a small slide and 3 drops of the reagent were added. 
Statistical analysis
Risk factors were compared between patients with positive or negative HCV testing using χ 2 test or Fischer's test as appropriated. For calculation of anti-HCV prevalence related to age, Student's t-test was applied. Multivariate analysis was conducted using logistic regression, considering Wald test for variable significance. Rapid test was validated by sensibility and specificity determination. A p value < 0.05 was considered statistically significant.
RESULTS
Seroprevalence by age and gender
During a period of 4 days, 816 (17.87%) subjects of 4,564 estimated residents in Tamboara were interviewed and tested for anti-HCV. The overall anti-HCV prevalence using Rapid Test Bioeasy was 4.28% (35 subjects), similar in males (3.85%) and females (4.53%). The anti-HCV prevalence according to age is showed in Figure 1 . The median age for positive and negative anti-HCV test was 60.49 (± 14.14) and 41.68 (± 20.25) years old respectively, with a p value < 0.001. 
Socioeconomic factors
The social-demographic variables are demonstrated in Table 1 . Ethnic group and marital status were not associated with presence of HCV infection. The prevalence of anti-HCV in subjects with no education or less than eight years of education was significantly higher than in the others (p = 0.012). Sadly, 15.14% of the population in Tamboara had less than one year of education.
Risk factors for hepatitis C
By univariate analysis, the significant risk factors for HCV infection were as follow: familial history of hepatitis (p = 0.04), injection with glass syringe (p < 0.001), vaccination with jet (needle-free) injection devices (p = 0.034), blood transfusion before 1993 (p < 0.001) and not safe sexual practice (p = 0.03). By multivariate analysis, only familial history of hepatitis (p = 0.001; OR = 6.41; 95% CI = 2.08-19.78) and age (p = 0.007; OR 1.06; 95% CI = 1.02-1.10) showed statistically significant values (Table 2) . Based on that, we constructed a ROC curve in order to identify an age associated to positive HCV status. After that, only participants with more than 45 years (n = 362) of age were analyzed. By multivariate analysis of this group, familial history of hepatitis continued to be the only significant risk factor of HCV infection (p = 0.001; OR 5.08; 95% CI = 1.99-12.99) ( Table 3) .
Rapid Test Bioeasy performance
The sensibility and specificity of the Rapid Test Bioeasy was estimated considering quimioluminescent immunoassay as gold standard for anti-HCV. Thirty three anti-HCV positive individuals and 41 anti-HCV negative by immuno-chromatographic test were submitted to quimioluminescent immunoassay ( Table 4 ). The sensitivity and specificity was 100.0% and 92.7% respectively, with an accuracy of 95.8% (95% CI = 91-100). 
Genotype distribution
The prevalence of HCV genotypes is shown in Figure 2 . Sixty-eight percent of positive anti-HCV residents were genotype 3 and only 11% were genotype 1. 
HCV status from family members of positive residents
Seventy eight family members from 28 anti-HCV positive subjects were investigated for anti-HCV with 5 (6.41%) of them showing positive results by Rapid Test Bioeasy and by PCR. The five anti-HCV positive were from 3 different families.
DISCUSSION
There are only few population-based studies on age-specifi c prevalence of HCV infection which demonstrate distinct epidemiologic profi les of HCV transmission worldwide. These profi les refl ect not only regional variations but also variations in the period during which there was an increased risk for acquiring HCV infection. In Tamboara, the age-specifi c anti-HCV prevalence is low in children and younger adults but increases sharply among older persons, who account for most of the infected individuals. The data suggests that the burden of disease might have already peaked. This type of pattern was also seen in Spain, 22 Italy 6 and Japan 23 and it is consistent with the fact that the risk for HCV infection was highest 30-50 years ago. Illegal use of injection drugs have been the dominant mode of HCV transmission in USA during the past 30 years 7 but it appears to have played a minor role in the population of Tamboara. In countries where the period of increased risk for HCV infection occurred in a distant past such as observed in this study, healthcare-related procedures performed both by professionals and nonprofessionals appear to have been a major mode of HCV transmission. The authorities responsible for health care in Tamboara had a hypothesis that the high prevalence of anti-HCV was related with jet injection devices. Up to 1990, vaccination with this technique was used especially for prevention of yellow fever in Brazil. An epide- miological survey by Souto et al. in a Center-West Brazilian city suggests that the jet injection device has facilitated hepatitis B contamination in the population. 24 In this study, some healthcare procedures related to anti-HCV transmission were identifi ed by univariate analysis. Injections with glass syringe, vaccination with jet injection devices and blood transfusion before 1993 were signifi cant risk factors. However, by multivariate analysis, these factors were not signifi cant.
In a recent survey, prevalence for anti-HCV ranging from 0.69%-1.89% was observed in the capital cities of Northeast, Center-West and in Federal District of Brazil. 25 In Tamboara, this prevalence was 4.3% is considered high for a place with not known risk factors. The strong relationship of risk of infection and the presence of family history of hepatitis suggests that the transmission of HCV have occurred among family members, but does not defi ne the exact routes. As hypothesized by Rao et al., many infections in the past were probably acquired from external sources in which more than one family member was contaminated at the same time. 26 Nevertheless, the lower prevalence in younger age groups in Tamboara suggests that the unknown exposure may no longer play a role in HCV transmission.
According to Campiotto et al., the HCV genotype 1 is more prevalent in all regions of Brazil with a median frequency of 64.9% and in the South, genotype 3 was more common (43.2%) than in the other regions. 27 Similar results were found by Focaccia et al. 28 In hemodialysis patients from Central Brazil, the genotype 3 was present in 7.6%. 29 In Tamboara, the great majority of HCV individuals carry genotype 3.
The study found a 6.41% prevalence of anti-HCV in members of the positive families. This data confi rms the important role of intrafamilial transmission in our population.
The accumulated incidence and anti-HCV prevalence in Tamboara has called the attention of local health care workers. Thus, better knowledge regarding this HCV epidemic area was important for the government to take effective decisions strategies. Based on this data, we now know that infection occurred in a distant past and there is no longer risk behavior related to HCV. Efforts from government and local health workers will become necessary for treating already infected subjects. This effort will be extremely effi cient in avoiding cirrhosis and hepatocellular carcinoma and it will have a social economic result better than the HCV prevention in Tamboara. The great majority of individuals infected by genotype 3 will become this strategy result even better and less expensive since genotype 3 virus has good response to interferon and ribavirin treatment.
By our knowledge, this epidemiological survey was the fi rst in Brazil to check the quality of the Rapid Test Bioeasy for anti-HCV as a screening test. The sensibility of a rapid immuno-chromatographic assay for the detection of anti-HCV antibodies have been evaluated previously on 421 HCV RNA positive samples from chronic carriers and compared with enzyme-linked immunoassays (ELISA) method. 30 The sensitivity of rapid test was 95.5% and false negative results were associated with human immunodefi ciency virus (HIV). Among HIV-negative people, the sensibility was 99.2% whereas among HIV positive one, this result was 77.5%. In our study, a specifi city of 92.7% and accuracy of 95.8% was observed for rapid test. Since Tamboara presents low HIV prevalence rates with only one positive case in 2007, the HIV status had not infl uenced rapid test performance. In this case, the test has showed to be simple, accurate and feasible, with adequate sensibility and specifi city. Based on this data, the immuno-chromatographic test for anti-HCV showed to be appropriated for population-based studies, in settings with limited facilities or when rapid results are required.
In conclusion, our data show high prevalence of anti-HCV positivity associated with familial history of hepatitis in a small town of south Brazil. The immuno-chromatographic rapid test has shown to be effi cient in population based surveys.
